US Stock MarketDetailed Quotes

RVPH Reviva Pharmaceuticals

Watchlist
  • 1.460
  • -0.040-2.67%
Close Jun 14 16:00 ET
  • 1.450
  • -0.010-0.68%
Post 16:42 ET
43.53MMarket Cap-918P/E (TTM)

Reviva Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
6.38%11.97M
26.18%23.37M
26.18%23.37M
-78.56%4.97M
-42.58%11.15M
-51.94%11.26M
-37.62%18.52M
-37.62%18.52M
-30.75%23.19M
-45.76%19.42M
-Cash and cash equivalents
6.38%11.97M
26.18%23.37M
26.18%23.37M
-78.56%4.97M
-42.58%11.15M
-51.94%11.26M
-37.62%18.52M
-37.62%18.52M
-30.75%23.19M
-45.76%19.42M
Prepaid assets
--779.6K
----
----
----
----
----
----
----
----
----
Other current assets
-54.84%743.38K
-17.55%332.93K
-17.55%332.93K
-51.15%414.74K
-43.56%690.44K
-10.89%1.65M
-76.47%403.82K
-76.47%403.82K
111.03%849.02K
66.69%1.22M
Total current assets
4.61%13.5M
25.24%23.7M
25.24%23.7M
-77.59%5.39M
-42.64%11.84M
-48.94%12.9M
-39.74%18.92M
-39.74%18.92M
-29.07%24.04M
-43.50%20.64M
Non current assets
Total non current assets
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total assets
4.61%13.5M
25.24%23.7M
25.24%23.7M
-77.59%5.39M
-42.64%11.84M
-48.94%12.9M
-39.74%18.92M
-39.74%18.92M
-29.07%24.04M
-43.50%20.64M
Liabilities
Current liabilities
Payables
99.98%5.72M
9.34%3.85M
9.34%3.85M
124.82%5.28M
3.72%2.65M
100.62%2.86M
590.81%3.52M
590.81%3.52M
457.96%2.35M
612.68%2.55M
-accounts payable
99.98%5.72M
9.34%3.85M
9.34%3.85M
124.82%5.28M
3.72%2.65M
100.62%2.86M
590.81%3.52M
590.81%3.52M
457.96%2.35M
612.68%2.55M
Current accrued expenses
138.22%7.22M
110.43%12.37M
110.43%12.37M
513.40%7.53M
229.37%6.34M
37.97%3.03M
220.24%5.88M
220.24%5.88M
122.08%1.23M
139.18%1.92M
Current debt and capital lease obligation
-50.26%332K
----
----
--222.5K
--222.5K
--667.5K
----
----
----
----
-Current debt
-50.26%332K
----
----
--222.5K
--222.5K
--667.5K
----
----
----
----
Current liabilities
120.91%14.49M
72.41%17.18M
72.41%17.18M
264.49%13.03M
105.66%9.21M
81.05%6.56M
324.85%9.96M
324.85%9.96M
267.23%3.58M
285.07%4.48M
Non current liabilities
Derivative product liabilities
-37.00%350.48K
42.16%806.66K
42.16%806.66K
726.32%873.41K
857.90%1.01M
96.08%556.31K
52.24%567.44K
52.24%567.44K
-83.76%105.7K
-87.58%105.7K
Total non current liabilities
-37.00%350.48K
42.16%806.66K
42.16%806.66K
726.32%873.41K
857.90%1.01M
96.08%556.31K
52.24%567.44K
52.24%567.44K
-83.76%105.7K
-87.58%105.7K
Total liabilities
108.56%14.84M
70.78%17.98M
70.78%17.98M
277.75%13.91M
123.01%10.22M
82.14%7.12M
287.46%10.53M
287.46%10.53M
126.61%3.68M
127.57%4.58M
Shareholders'equity
Share capital
36.53%2.79K
36.53%2.79K
36.53%2.79K
10.81%2.27K
49.70%2.27K
35.16%2.05K
41.72%2.05K
41.72%2.05K
52.77%2.04K
13.08%1.51K
-common stock
36.53%2.79K
36.53%2.79K
36.53%2.79K
10.81%2.27K
49.70%2.27K
35.16%2.05K
41.72%2.05K
41.72%2.05K
52.77%2.04K
13.08%1.51K
-Preferred stock
--0
--0
--0
----
----
----
--0
--0
----
----
Retained earnings
-45.02%-141.79M
-41.29%-134.35M
-41.29%-134.35M
-45.34%-120.71M
-38.57%-110.22M
-31.78%-97.77M
-42.29%-95.09M
-42.29%-95.09M
-31.52%-83.05M
-30.67%-79.54M
Paid-in capital
35.62%140.44M
35.35%140.07M
35.35%140.07M
8.49%112.19M
16.99%111.84M
8.37%103.56M
8.34%103.49M
8.34%103.49M
8.38%103.41M
0.22%95.6M
Total stockholders'equity
-123.26%-1.35M
-31.87%5.72M
-31.87%5.72M
-141.84%-8.52M
-89.91%1.62M
-72.92%5.78M
-70.74%8.39M
-70.74%8.39M
-36.91%20.36M
-53.48%16.06M
Total equity
-123.26%-1.35M
-31.87%5.72M
-31.87%5.72M
-141.84%-8.52M
-89.91%1.62M
-72.92%5.78M
-70.74%8.39M
-70.74%8.39M
-36.91%20.36M
-53.48%16.06M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments 6.38%11.97M26.18%23.37M26.18%23.37M-78.56%4.97M-42.58%11.15M-51.94%11.26M-37.62%18.52M-37.62%18.52M-30.75%23.19M-45.76%19.42M
-Cash and cash equivalents 6.38%11.97M26.18%23.37M26.18%23.37M-78.56%4.97M-42.58%11.15M-51.94%11.26M-37.62%18.52M-37.62%18.52M-30.75%23.19M-45.76%19.42M
Prepaid assets --779.6K------------------------------------
Other current assets -54.84%743.38K-17.55%332.93K-17.55%332.93K-51.15%414.74K-43.56%690.44K-10.89%1.65M-76.47%403.82K-76.47%403.82K111.03%849.02K66.69%1.22M
Total current assets 4.61%13.5M25.24%23.7M25.24%23.7M-77.59%5.39M-42.64%11.84M-48.94%12.9M-39.74%18.92M-39.74%18.92M-29.07%24.04M-43.50%20.64M
Non current assets
Total non current assets --0--0--0--0--0--0--0--0--0--0
Total assets 4.61%13.5M25.24%23.7M25.24%23.7M-77.59%5.39M-42.64%11.84M-48.94%12.9M-39.74%18.92M-39.74%18.92M-29.07%24.04M-43.50%20.64M
Liabilities
Current liabilities
Payables 99.98%5.72M9.34%3.85M9.34%3.85M124.82%5.28M3.72%2.65M100.62%2.86M590.81%3.52M590.81%3.52M457.96%2.35M612.68%2.55M
-accounts payable 99.98%5.72M9.34%3.85M9.34%3.85M124.82%5.28M3.72%2.65M100.62%2.86M590.81%3.52M590.81%3.52M457.96%2.35M612.68%2.55M
Current accrued expenses 138.22%7.22M110.43%12.37M110.43%12.37M513.40%7.53M229.37%6.34M37.97%3.03M220.24%5.88M220.24%5.88M122.08%1.23M139.18%1.92M
Current debt and capital lease obligation -50.26%332K----------222.5K--222.5K--667.5K----------------
-Current debt -50.26%332K----------222.5K--222.5K--667.5K----------------
Current liabilities 120.91%14.49M72.41%17.18M72.41%17.18M264.49%13.03M105.66%9.21M81.05%6.56M324.85%9.96M324.85%9.96M267.23%3.58M285.07%4.48M
Non current liabilities
Derivative product liabilities -37.00%350.48K42.16%806.66K42.16%806.66K726.32%873.41K857.90%1.01M96.08%556.31K52.24%567.44K52.24%567.44K-83.76%105.7K-87.58%105.7K
Total non current liabilities -37.00%350.48K42.16%806.66K42.16%806.66K726.32%873.41K857.90%1.01M96.08%556.31K52.24%567.44K52.24%567.44K-83.76%105.7K-87.58%105.7K
Total liabilities 108.56%14.84M70.78%17.98M70.78%17.98M277.75%13.91M123.01%10.22M82.14%7.12M287.46%10.53M287.46%10.53M126.61%3.68M127.57%4.58M
Shareholders'equity
Share capital 36.53%2.79K36.53%2.79K36.53%2.79K10.81%2.27K49.70%2.27K35.16%2.05K41.72%2.05K41.72%2.05K52.77%2.04K13.08%1.51K
-common stock 36.53%2.79K36.53%2.79K36.53%2.79K10.81%2.27K49.70%2.27K35.16%2.05K41.72%2.05K41.72%2.05K52.77%2.04K13.08%1.51K
-Preferred stock --0--0--0--------------0--0--------
Retained earnings -45.02%-141.79M-41.29%-134.35M-41.29%-134.35M-45.34%-120.71M-38.57%-110.22M-31.78%-97.77M-42.29%-95.09M-42.29%-95.09M-31.52%-83.05M-30.67%-79.54M
Paid-in capital 35.62%140.44M35.35%140.07M35.35%140.07M8.49%112.19M16.99%111.84M8.37%103.56M8.34%103.49M8.34%103.49M8.38%103.41M0.22%95.6M
Total stockholders'equity -123.26%-1.35M-31.87%5.72M-31.87%5.72M-141.84%-8.52M-89.91%1.62M-72.92%5.78M-70.74%8.39M-70.74%8.39M-36.91%20.36M-53.48%16.06M
Total equity -123.26%-1.35M-31.87%5.72M-31.87%5.72M-141.84%-8.52M-89.91%1.62M-72.92%5.78M-70.74%8.39M-70.74%8.39M-36.91%20.36M-53.48%16.06M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg